Virax Biolabs Group Raises $5 Million in Private Placement
I'm PortAI, I can summarize articles.
Virax Biolabs Group Ltd. has entered into definitive agreements for a $5 million private placement, issuing 12,500,000 ordinary shares and options to purchase an additional 12,500,000 shares at $0.40 per share. The proceeds will be used for working capital and general corporate purposes. H.C. Wainwright & Co. is the exclusive placement agent.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments